Mucotoss indications
Mucotoss is a mucolytic agent for the adjunctive therapy of respiratory tract disorders characterised by excessive, viscous mucus, including chronic obstructive airways disease.
Uses of Mucotoss in details
Mucotoss is used along with other medications as adjunctive therapy to treat conditions of the respiratory tract which causes difficulty in breathing, including chronic obstructive airways disease.
Mucotoss description
Mucotoss is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Mucotoss should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. Mucotoss is produced by alkylation of cysteine with chloroacetic acid.
Mucotoss dosage
Capsule: Adult and Children ≥12 years: 1 capsule. Forte Suspension: Adult and Children ≥12 years: 5 mL (1 tsp). 100 mg/5 mL Pediatric Suspension: Children 8-12 years: 15 mL (3 tsp), 4-7 years: 10 mL (2 tsp), 2-3 years: 5 mL (1 tsp). 200 mg/5 mL Pediatric Suspension: Children 8-12 years: 7.5 mL, 4-7 years: 5 mL, 2-3 years: 2.5 mL. InfantOral Drops:
Infants 1-2 years: 1.5 mL. All doses to be taken orally every 8 hrs.
Mucotoss interactions
mixing Mucotoss with pholcodine linctus causes precipitation of Mucotoss from solution but no information is given on whether this incompatibility is with the pholcodine or some component of the formulation used.
Mucotoss side effects
Capsules, Syrup and Paediatric Syrup:
Immune System Disorders
There have been reports of anaphylactic reactions and fixed drug eruption.
Skin and subcutaneous tissue disorders
There have been reports of skin rashes and allergic skin eruptions.
Capsules and Syrup:
Gastrointestinal disorders
There have been rare reports of gastrointestinal bleeding occurring during treatment with Mucotoss.
Mucotoss contraindications
Adult Syrup: Gastroduodenal ulceration.
Children Syrup: Known hypersensitivity to any of the components of Mucotoss Children Syrup, in particular to parabens. Children <2 years due to risk of worsening airway congestion.
Active ingredient matches for Mucotoss:
Carbocisteine in Brazil.
List of Mucotoss substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Mucothio S (Japan) | |
| Mucotreis (Italy, Latvia, Romania) | |
| Mucotreis BB (Italy) | |
| Mucotron (Japan) | |
| Mucotron 5% (Japan) | |
| Mucotrophir (France) | |
| Mucovital (Estonia, Spain) | |
| Muflex (Thailand) | |
| Muflex 375 mg x 50 x 10's (T. O. Chemicals) | |
| Muflex 250 mg/5 mL x 60 mL (T. O. Chemicals) | |
| Muflex syr 250 mg/5 mL 60 mL x 1's (T. O. Chemicals) | |
| Muflex tab 375 mg 50 x 10's (T. O. Chemicals) | |
|
sponsored
| |
| Mukolin (Georgia, Lithuania) | |
| Mukolin 2% (Lithuania) | |
| Mukolin 5% (Lithuania) | |
| Mukolina (Poland) | |
| Mukoliz (Turkey) | |
| Mukolİz | |
| Mukotik (Turkey) | |
| Mukotik Fort (Turkey) | |
| Mukotik Pediatrik (Turkey) | |
| Murhinal (Thailand) | |
| Murhinol (Thailand) | |
| Murhinol 375 mg x 50 x 10's (Farmaline) | |
| Murhinol 100 mg/5 mL x 60 mL (Farmaline) | |
| Murhinol 250 mg/5 mL x 60 mL (Farmaline) | |
| Murhinol syr 100 mg/5 mL 60 mL x 1's (Farmaline) | |
| Murhinol syr 250 mg/5 mL 60 mL x 1's (Farmaline) | |
| Murhinol tab 375 mg 50 x 10's (Farmaline) | |
| Nattermann Solvopect (Netherlands) | |
| Neocitran Expectorant (Hungary) | |
| Neumohem (Dominican Republic) | |
| Nivicof (Philippines) | |
| Nivicof 500 mg x 100's (Medhaus) | |
| Nivicof 100 mg/5 mL x 60 mL (Medhaus) | |
| Nivicof 50 mg/1 mL x 15 mL (Medhaus) | |
| Nivicof cap 500 mg 100's (Medhaus) | |
| Nivicof oral drops 50 mg/mL 15 mL x 1's (Medhaus) | |
| Nivicof syr 100 mg/5 mL 60 mL x 1's (Medhaus) | |
| Nokof (Bangladesh) | |
| Nokof DS (Bangladesh) | |
| Oberland Apotheke Hustenlöser (Switzerland) | |
| Pabron Cough (Malaysia) | |
| Pabron Cough / lemon & mint flavour 250 mg/5 mL x 120 mL (Taisho) | $ 3.34 |
| Pabron Cough 10's (Taisho) | |
| Pabron Cough / Lemon flavor 60 mL (Taisho) | |
See 916 substitutes for Mucotoss | |
Reviews
The results of a survey conducted on ndrugs.com for Mucotoss are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Mucotoss. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
1 consumer reported useful
Was the Mucotoss drug useful in terms of decreasing the symptom or the disease?According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
| Users | % | ||
|---|---|---|---|
| Not useful | 1 | 100.0% | |
Consumer reported price estimates
No survey data has been collected yet1 consumer reported time for results
To what extent do I have to use Mucotoss before I begin to see changes in my health conditions?As part of the reports released by ndrugs.com website users, it takes 1 week and a few days before you notice an improvement in your health conditions.
Please note, it doesn't mean you will start to notice such health improvement in the same time frame as other users. There are many factors to consider, and we implore you to visit your doctor to know how long before you can see improvements in your health while taking Mucotoss. To get the time effectiveness of using Mucotoss drug by other patients, please click here.
| Users | % | ||
|---|---|---|---|
| 1 week | 1 | 100.0% | |
8 consumers reported age
| Users | % | ||
|---|---|---|---|
| 16-29 | 3 | 37.5% | |
| 1-5 | 2 | 25.0% | |
| 6-15 | 1 | 12.5% | |
| 46-60 | 1 | 12.5% | |
| > 60 | 1 | 12.5% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
